What other physicians say:

We’re convinced we’ve developed a service that maximizes the potential for the latest genetic information to positively impact behavior and accurately inform health decisions.

-David Agus, M.D.,

USC Center for Applied Molecular Medicine; co-founder, Navigenics, Inc.

Clinical relevance

Expand from diagnostic medicine to preventive medicine with Navigenics. Genetic risk information can inform clinical decision-making and preventative guidance.

Age-related macular degeneration (AMD). With Navigenics' genotyping, physicians have the potential to identify the 5 percent of people estimated to have 3.5 or more times the average AMD risk. Learn more. >

Breast cancer. With our genotyping, you have the potential to identify the 15 percent of people whose estiamted average breast cancer risk is 50 percent greater than the population's risk. Learn more. >

Prostate cancer. Our genotyping gives physicians the opportunity to identify the 20 percent of people whose estimated average risk is 50 percent greater than the population's risk. Learn more. >

Resources

Downloads

Quick links

View Demo Request Info

Free Information Kit

Free Information Kit

Navigenics physician kit

Order